OptimizeRx Corporation (OPRX) financial statements and ratios from SEC XBRL: revenue $109.43M (TTM), net margin 4.7%, revenue growth 18.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $109.43M |
| Net Margin | 4.7% |
| Revenue Growth (YoY) | 18.8% |
| EPS Growth (YoY) | -125.5% |
| FCF Growth (YoY) | 290.6% |
| EV / EBITDA | 18.9 |
| Price / Book | 1.12 |
| Price / Sales | 1.49 |
| FCF Yield | 16.1% |
| DCF Value (model) | $4.02 |
| DCF Upside vs Price | -47.9% |
| Altman Z-Score | 2.29 (grey) |
| Piotroski F-Score | 8/9 |
| Sector P/E (Technology) | 33.9 |
OPRX overview · OPRX earnings · OPRX KPIs · OPRX investor relations · OPRX ownership · OPRX peers · OPRX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.